Ryan J. Lowery

Ryan Lowery advises public and private companies, private equity firms and special committees in U.S. and cross-border mergers, acquisitions, divestitures, strategic investments, carve-outs and restructurings. He also counsels clients on shareholder activism, takeover preparedness and corporate governance matters.

Notable representations include:

• Argo Group International Holdings, Ltd. in its $1.1 billion acquisition by Brookfield Reinsurance Ltd. and its successful defense of a proxy contest brought by Capital Returns Master, Ltd.
• the special committee of the board of directors of Myovant Sciences Ltd. in the $1.7 billion acquisition by Sumitovant Biopharma Ltd. of the remaining 48% stake in Myovant that Sumitovant did not already own
• Hg Capital in numerous transactions, including:
  • its acquisition of AuditBoard
  • the investment made in Intelerad, a portfolio company of Hg, by TA Associates
  • the merger of Norstella, a portfolio company of Hg and Welsh Carson Anderson & Stowe, with Citeline, a portfolio company of Warburg Pincus, which created a combined entity valued at $5 billion
  • the acquisition by HHAeXchange, a portfolio company of Hg and Cressey, of Sandata Technologies
• CoreLogic, Inc. in its $6 billion acquisition by funds managed by Stone Point Capital and Insight Partners, and in its previous proxy fight with Senator Investment Group and Cannae Holdings following their unsolicited acquisition proposal
• CC Capital in its pending $250 million investment in The Westaim Corporation creating an integrated insurance and asset management platform
• HPS Investment Partners in its acquisition of Spectrum Automotive Holdings
• Argus Group Holdings Limited on its acquisition of a significant stake of shares in BF&M Limited from Camellia Plc, followed by an all-stock merger of Argus with BF&M Limited
• Aspirational Consumer Lifestyle Corporation in its $2.1 billion merger with private aviation platform Wheels Up Partners Holdings LLC
• BridgeBio Pharma, Inc. in its $1 billion acquisition of the remaining 36% stake in Eidos Therapeutics, Inc. that it did not already own
• IAC/InterActiveCorp in its $600 million acquisition of Care.com
• Vericity, Inc. in its $170 million merger with iA American Holdings, Inc.
• FedEx Corporation in its settlement with activist shareholder D.E. Shaw
• iHeartMedia in its adoption of a shareholder rights plan and other corporate governance matters
• Navient Corporation in its evaluation and rejection of a $3.2 billion unsolicited acquisition proposal from Canyon Capital and Platinum Equity and its subsequent settlement of a threatened proxy contest